BridgeMD
New treatment option for Alcohol Use Disorder
Official title Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder
ClinicalTrials.gov ID: NCT05997212
What this study is testing
- What it's testing
- Alcohol Use Disorder (AUD) is a major public health problem that affects the physical, social, family, and mental integrity of the sufferer. Behavioral self-regulation is compromised in AUD, and a benefit has been reported with the application of repetitive transcranial magnetic stimulation and emotional self-regulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 59
You may be able to join if
- Men and women of 25 to 59 years old
- The reading level of at least 6th grade of primary (equivalent to fifth grade of elementary school).
- Alcohol users with and AUDIT ≥ 20 puntos
- Abstinence from alcohol consumption from 8 weeks to 5 years, with CIWA-Ar scale scores ≤ 9 points.
- No disabling neuropsychiatric conditions (i.e. Schizophrenia)
You likely can't join if
- Individuals with symptoms of severe agitation or who are unable to cooperate in the study
- History of epilepsy
- Sudden onset of stroke, focal neurological findings such as hemiparesis, sensory loss, visual field deficits and lack of coordination.
- Seizures or gait disturbances
- History of severe psychiatric disorders.
- Alterations in a conventional electroencephalogram.
See the full eligibility criteria
- Men and women of 25 to 59 years old
- The reading level of at least 6th grade of primary (equivalent to fifth grade of elementary school).
- Alcohol users with and AUDIT ≥ 20 puntos
- Abstinence from alcohol consumption from 8 weeks to 5 years, with CIWA-Ar scale scores ≤ 9 points.
- No disabling neuropsychiatric conditions (i.e. Schizophrenia)
- No substance use disorders except alcohol and nicotine.
- BrAC (Breath Alcohol) = 0.00 mg/dl in each of the assessments.
- No traces of alcohol consumption using urine test strips.
- No contraindications for TMS therapy.
- Individuals with symptoms of severe agitation or who are unable to cooperate in the study
- History of epilepsy
- Sudden onset of stroke, focal neurological findings such as hemiparesis, sensory loss, visual field deficits and lack of coordination.
- Seizures or gait disturbances
- History of severe psychiatric disorders.
- Alterations in a conventional electroencephalogram.
- Pacemakers or intracranial metallic objects. Elimination criteria
- At the subject's request
- The presence of adverse incidents that deteriorate the subject's health and would limit continuation of rTMS treatment.
- Exacerbation of cognitive or behavioral symptoms during treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Querétaro City, Querétaro, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Querétaro City, Querétaro, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.